John N van den Anker1, Karel Allegaert2. 1. Division of Pediatric Clinical Pharmacology; Department of Pediatrics; Children's National Health System; Washington, DC; Division of Paediatric Pharmacology and Pharmacometrics; University of Basel Children's Hospital; Basel, Switzerland; Intensive Care and Department of Pediatric Surgery; Erasmus Medical Center-Sophia Children's Hospital; Rotterdam, the Netherlands. Electronic address: jvandena@cnmc.org. 2. Intensive Care and Department of Pediatric Surgery; Erasmus Medical Center-Sophia Children's Hospital; Rotterdam, the Netherlands; Department of Development and Regeneration; KU Leuven; Leuven, Belgium.
Authors: M R Alcorta-García; C N López-Villaseñor; G Sánchez-Ferrer; H Flores-Mendoza; F Castorena-Torres; M A Aguilar-Torres; C M Sepúlveda-Treviño; J A Hernández-Hernández; R C López-Sánchez; V J Lara-Díaz Journal: Mol Cell Pediatr Date: 2020-06-01
Authors: Ram Patel; Katelyn Sushko; John van den Anker; Samira Samiee-Zafarghandy Journal: Int J Environ Res Public Health Date: 2022-02-14 Impact factor: 3.390